DIAsource Overview
- Founded
- 1996

- Status
- Acquired/Merged
- Employees
- 80

- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 3
- Investments
- 2
DIAsource General Information
Description
Manufacturer, developer and marketer of clinical diagnostics products designed to treat endocrinology and infectious diseases. The company's focus lies in offering a panel of accurate, reliable assays that allow the performant detection and measurement of various forms of Vitamin D metabolites, as well as developing new antibodies and assays to measure relevant biomarkers, enabling clients to detect and monitor endocrine disorders and infectious and auto-immune diseases.
Contact Information
- Rue du Bosquet, 2
- 1348 Louvain-la-Neuve
- Belgium
DIAsource Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore DIAsource‘s full profile, request access.
Request a free trialDIAsource Comparisons
Industry
00000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialDIAsource Competitors (27)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
SomaLogic | Private Equity-Backed | Boulder, CO | 000 | 00.000 | 000000000 | 00.000 |
000000000 00000000 | Venture Capital-Backed | Dublin, Ireland | 00 | 000.00 | 0000000000 0 | 000.00 |
000000 | Venture Capital-Backed | Frederick, MD | 00 | 000.00 | 000000000 - | 000.00 |
00000000 000000000 | Formerly PE-Backed | Fremont, CA | 000 | 000 | 000000000000 | 000 |
0000000 | Venture Capital-Backed | San Diego, CA | 00 | 00.000 | 00000000000 | 00.000 |
DIAsource Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Béatrice de Borman | Chief Executive Officer | ||
Corentin Frippiat | Financial Controller | ||
Peter Kerckx | International Sales Director & Business Segment Manager RIA |
DIAsource Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
0000 0000000 00.0 | Self | Interim Executive Chairman | 000 0000 |
DIAsource Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialDIAsource Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore DIAsource‘s full profile, request access.
Request a free trialDIAsource Investments & Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 0000 0000000 | 30-Jul-2018 | 000000000 00000 00 | Buildings and Property | ||
Viro-Immun Diagnostics | 01-Sep-2017 | Merger/Acquisition | Diagnostic Equipment |